Market Size of Global Venous Stents Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 9.80 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Venous Stents Market Analysis
The venous stents market studied was projected to grow with a CAGR of nearly 9.8% over the forecast period (2022-2027).
Due to the high infection rate and lockdown regulations brought on by the COVID-19 pandemic, surgical procedures have been affected. Additionally, patients with cardiovascular diseases have experienced delays in diagnosis and treatment as a result of fewer people visiting hospitals and diagnostic facilities, which has had an effect on the market for coronary stents. According to the study titled "The impact of the COVID-19 pandemic on vascular surgery: Health care systems, economic, and clinical implications" published in the Seminar in Vascular Surgery in September 2021, in ambulatory care and outpatient clinics, 89.2% of vascular surgeons reported changes to their practise, including fewer hours worked (71%), and the use of telemedicine services (81.1%). The daily average for inpatient consultations decreased to just 1.81 per day and surgical volume decreased by 71.7% and 96.5%, respectively. Vascular surgery has undoubtedly had a considerable overall impact. Therefore, the market for venous stents was considerably hit by the COVID-19 drop in vascular surgery, but it is anticipated that market will resume growth over the projection period.
The major factor attributing to the growth of the market is the rising incidence of chronic symptomatic venous diseases like chronic deep vein thrombosis, Post-thrombotic syndrome, May-Thurner syndrome, Nutcracker syndrome, Hemodialysis/arteriovenous fistulae, etc. couple with the rising in the geriatric population.
According to the study titled "Incidence of proximal deep vein thrombosis in medical critical care patients" published in Thrombosis Journal in February 2022, deep vein thrombosis affects 13%-31% of medical critical care patients (DVT). The incidence proportion was 10.1%, and the prevalence was 5.7%. As per the statistics, there is a significant rise in the patient pool which is expected to boost the market growth. The other important factor propelling the market growth is the increasing geriatric population who are prone to such diseases. Additionally, according to the study titled "Prevalence of post-thrombotic syndrome in a cohort of upper extremity vein thrombosis" published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders in January 2022, 14.1% of cases of upper extremity PTS (UE-PTS) occurred following upper extremity venous thrombosis (UEVT). A stroke along with a reduction in limb mobility was a risk factor for Post-thrombotic syndrome (PTS). Thus, growing prevalence of venous diseases is expected to boost the demand for venous stent devices, thereby boosting the market growh.
Additionally, it is anticipated that the launch of new products and improvements in stent technology made by the leading market participants in the region will accelerate growth in the market under study. For Instance, in October 2020, Medtronic plc has received United States Food and Drug Administration (FDA) approval for the Abre venous self-expanding stent system. This device is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction, also known as deep venous obstruction.
However, the lack of awareness of the venous stents and the high cost of stenting are major drawbacks for market growth.
Venous Stents Industry Segmentation
Aa per the scope of the report, venous stents are mesh tubes, inserted in the veins for chronic symptomatic venous diseases. They expand against the narrowed or obstructed veins and keep them open. The Venous Stents market is segmented by Application (Leg, Chest, Abdomen, Arm), Disease (Chronic Deep Vein, Thrombosis, Post Thrombotic Syndrome, Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.
| By Application | |
| Leg | |
| Chest | |
| Abdomen | |
| Others |
| By Disease | |
| Chronic Deep Vein Thrombosis | |
| Post Thrombotic Syndrome | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Venous Stents Market Size Summary
The venous stents market is poised for significant growth, driven by the increasing prevalence of chronic venous diseases such as deep vein thrombosis and post-thrombotic syndrome, particularly among the aging population. The market experienced a temporary setback due to the COVID-19 pandemic, which disrupted surgical procedures and delayed diagnoses and treatments. However, the market is expected to recover and expand, supported by advancements in stent technology and the introduction of new products by leading companies. The growing incidence of venous diseases and the rising geriatric population are key factors propelling market growth, despite challenges such as high costs and limited awareness of venous stents.
North America is anticipated to dominate the venous stents market throughout the forecast period, attributed to the presence of major industry players, advanced medical technologies, and robust healthcare infrastructure. The region benefits from substantial healthcare investments, favorable government initiatives, and increased research collaborations, which are expected to drive market expansion. The competitive landscape is characterized by a few major players engaging in product innovation, acquisitions, and mergers to maintain their market position. Companies like Boston Scientific Corporation, Medtronic Plc, and Gore Medical are at the forefront, contributing to the market's growth through strategic advancements and regulatory approvals for new stent systems.
Global Venous Stents Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Chronic Symptomatic Venous Diseases
-
1.2.2 Increasing Geriatric Population
-
-
1.3 Market Restraints
-
1.3.1 High Cost of the Treatment and Lack of Awareness
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - by USD million)
-
2.1 By Application
-
2.1.1 Leg
-
2.1.2 Chest
-
2.1.3 Abdomen
-
2.1.4 Others
-
-
2.2 By Disease
-
2.2.1 Chronic Deep Vein Thrombosis
-
2.2.2 Post Thrombotic Syndrome
-
2.2.3 Others
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Venous Stents Market Size FAQs
What is the current Global Venous Stents Market size?
The Global Venous Stents Market is projected to register a CAGR of 9.80% during the forecast period (2024-2029)
Who are the key players in Global Venous Stents Market?
Gore Medical, Cook Medical, Boston Scientific Corporation, Becton, Dickinson and Company and Medtronic Plc are the major companies operating in the Global Venous Stents Market.
